NOVO NORDISK INC FDA Approval ANDA 761156

ANDA 761156

NOVO NORDISK INC

FDA Drug Application

Application #761156

Documents

Letter2020-09-01
Label2020-09-04

Application Sponsors

ANDA 761156NOVO NORDISK INC

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTION10MG/1.5ML0SOGROYASOMPACITAN-BECO

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP2020-08-28STANDARD

Submissions Property Types

ORIG1Null6

CDER Filings

NOVO NORDISK INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 761156
            [companyName] => NOVO NORDISK INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"SOGROYA","activeIngredients":"SOMPACITAN-BECO","strength":"10MG\/1.5ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"08\/28\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 1 - New Molecular Entity","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2020\\\/761156Orig1s000ltr.pdf\"}]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-08-28
        )

)

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.